Cargando…

Expression of combined interference of slug and FoxC2 in endometrial carcinoma and its clinicopathological relationship

BACKGROUND: Endometrial carcinoma is one of the three major malignant tumors in female reproductive system. The current research aimed to investigate the relationship between the Slug and FoxC2 expression and the proliferation, invasion and metastasis of endometrial carcinoma. METHODS: The expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Qing, Tang, Mingyang, Wu, Ligao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797351/
https://www.ncbi.nlm.nih.gov/pubmed/35117893
http://dx.doi.org/10.21037/tcr-20-809
_version_ 1784641529794527232
author Zhu, Qing
Tang, Mingyang
Wu, Ligao
author_facet Zhu, Qing
Tang, Mingyang
Wu, Ligao
author_sort Zhu, Qing
collection PubMed
description BACKGROUND: Endometrial carcinoma is one of the three major malignant tumors in female reproductive system. The current research aimed to investigate the relationship between the Slug and FoxC2 expression and the proliferation, invasion and metastasis of endometrial carcinoma. METHODS: The expression of Slug and FoxC2 genes between 124 endometrial carcinoma tissues and 35 normal endometrial tissues was analyzed through immunohistochemistry. The endometrial carcinoma cell lines Ishikawa and RL-952 were cultured, the Slug-shRNA and FoxC2-shRNA expression vectors were constructed, and the endometrial carcinoma cells interfering with the expression of Slug and FoxC2 genes were also established. Western blotting and RT-PCR were employed to verify whether shRNA could down regulate the expression of Slug and FoxC2 genes. Additionally, the proliferation, migration and invasion capacities in both cell lines after interfering with Slug and FoxC2 was detected through CCK-8 and Transwell assay respectively. Furthermore, MMP2 and MMP9 were detected by ELISA and epithelial-mesenchymal transition (EMT) related proteins including E-cadherin, N-cadherin and Vimentin were assessed by Western blotting analysis. RESULTS: Compared with normal endometrial tissues, the Slug and FoxC2 expression levels in endometrial carcinoma tissues were remarkably increased. shRNAs transfection significantly down-regulated expressions in both endometrial carcinoma cell lines. The proliferation, invasion and migration ability were significantly inhibited by Slug-shRNA and FoxC2-shRNA compared with the control group. The expression of E-cadherin was increased while the expression of N-cadherin, Vimentin, MMP-2 and MMP-9 was suppressed by the Slug-shRNA and FoxC2-shRNA. CONCLUSIONS: Slug and FoxC2 could be used as a prognostic factor of endometrial carcinoma. Interfering with the expression of Slug and FoxC2 in endometrial carcinoma cell lines could effectively inhibit the proliferation, invasion and migration, and its mechanism is related to the inhibition of EMT. Slug and FoxC2 are potential targets for the treatment of endometrial carcinoma.
format Online
Article
Text
id pubmed-8797351
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87973512022-02-02 Expression of combined interference of slug and FoxC2 in endometrial carcinoma and its clinicopathological relationship Zhu, Qing Tang, Mingyang Wu, Ligao Transl Cancer Res Original Article BACKGROUND: Endometrial carcinoma is one of the three major malignant tumors in female reproductive system. The current research aimed to investigate the relationship between the Slug and FoxC2 expression and the proliferation, invasion and metastasis of endometrial carcinoma. METHODS: The expression of Slug and FoxC2 genes between 124 endometrial carcinoma tissues and 35 normal endometrial tissues was analyzed through immunohistochemistry. The endometrial carcinoma cell lines Ishikawa and RL-952 were cultured, the Slug-shRNA and FoxC2-shRNA expression vectors were constructed, and the endometrial carcinoma cells interfering with the expression of Slug and FoxC2 genes were also established. Western blotting and RT-PCR were employed to verify whether shRNA could down regulate the expression of Slug and FoxC2 genes. Additionally, the proliferation, migration and invasion capacities in both cell lines after interfering with Slug and FoxC2 was detected through CCK-8 and Transwell assay respectively. Furthermore, MMP2 and MMP9 were detected by ELISA and epithelial-mesenchymal transition (EMT) related proteins including E-cadherin, N-cadherin and Vimentin were assessed by Western blotting analysis. RESULTS: Compared with normal endometrial tissues, the Slug and FoxC2 expression levels in endometrial carcinoma tissues were remarkably increased. shRNAs transfection significantly down-regulated expressions in both endometrial carcinoma cell lines. The proliferation, invasion and migration ability were significantly inhibited by Slug-shRNA and FoxC2-shRNA compared with the control group. The expression of E-cadherin was increased while the expression of N-cadherin, Vimentin, MMP-2 and MMP-9 was suppressed by the Slug-shRNA and FoxC2-shRNA. CONCLUSIONS: Slug and FoxC2 could be used as a prognostic factor of endometrial carcinoma. Interfering with the expression of Slug and FoxC2 in endometrial carcinoma cell lines could effectively inhibit the proliferation, invasion and migration, and its mechanism is related to the inhibition of EMT. Slug and FoxC2 are potential targets for the treatment of endometrial carcinoma. AME Publishing Company 2020-09 /pmc/articles/PMC8797351/ /pubmed/35117893 http://dx.doi.org/10.21037/tcr-20-809 Text en 2020 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Original Article
Zhu, Qing
Tang, Mingyang
Wu, Ligao
Expression of combined interference of slug and FoxC2 in endometrial carcinoma and its clinicopathological relationship
title Expression of combined interference of slug and FoxC2 in endometrial carcinoma and its clinicopathological relationship
title_full Expression of combined interference of slug and FoxC2 in endometrial carcinoma and its clinicopathological relationship
title_fullStr Expression of combined interference of slug and FoxC2 in endometrial carcinoma and its clinicopathological relationship
title_full_unstemmed Expression of combined interference of slug and FoxC2 in endometrial carcinoma and its clinicopathological relationship
title_short Expression of combined interference of slug and FoxC2 in endometrial carcinoma and its clinicopathological relationship
title_sort expression of combined interference of slug and foxc2 in endometrial carcinoma and its clinicopathological relationship
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797351/
https://www.ncbi.nlm.nih.gov/pubmed/35117893
http://dx.doi.org/10.21037/tcr-20-809
work_keys_str_mv AT zhuqing expressionofcombinedinterferenceofslugandfoxc2inendometrialcarcinomaanditsclinicopathologicalrelationship
AT tangmingyang expressionofcombinedinterferenceofslugandfoxc2inendometrialcarcinomaanditsclinicopathologicalrelationship
AT wuligao expressionofcombinedinterferenceofslugandfoxc2inendometrialcarcinomaanditsclinicopathologicalrelationship